Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells

• Autori principali: Tzu-En Huang (Autore), Yi-Ning Deng (Autore), Jui-Ling Hsu (Autore), Wohn-Jenn Leu (Autore), Elena Marchesi (Autore), Massimo L. Capobianco (Autore), Paolo Marchetti (Autore), Maria Luisa Navacchia (Autore), Jih-Hwa Guh (Autore), Daniela Perrone (Autore), Lih-Ching Hsu (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2020-11-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy in adults and accounts for 85-90% of all primary liver cancer. Based on the estimation by the International Agency for Research on Cancer in 2018, liver cancer is the fourth leading cause of cancer death globally. Dihydroarte...